Massachusetts Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.84M Buy
23,607
+600
+3% +$69.3K 1.23% 27
2025
Q4
$2.42M Buy
23,007
+808
+4% +$75.8K 1.13% 35
2025
Q3
$1.86M Buy
22,199
+225
+1% +$18.5K 0.92% 47
2025
Q2
$1.74M Buy
21,974
+75
+0.3% +$5.96K 0.98% 43
2025
Q1
$1.97M Sell
21,899
-550
-2% -$51.4K 1.35% 34
2024
Q4
$2.23M Sell
22,449
-25
-0.1% -$2.58K 1.38% 27
2024
Q3
$2.55M Buy
22,474
+100
+0.4% +$11.9K 1.61% 19
2024
Q2
$2.77M Buy
22,374
+575
+3% +$74.1K 1.86% 11
2024
Q1
$2.88M Buy
21,799
+225
+1% +$27.7K 2.03% 10
2023
Q4
$2.35M Buy
21,574
+42
+0.2% +$4.36K 1.9% 12
2023
Q3
$2.22M Sell
21,532
-200
-0.9% -$21.6K 2.04% 12
2023
Q2
$2.51M Buy
21,732
+250
+1% +$28.4K 2.4% 10
2023
Q1
$2.29M Sell
21,482
-450
-2% -$48.6K 2.36% 11
2022
Q4
$2.36M Buy
+21,932
New +$2.24M 2.28% 10

Other funds holding MRK

Massachusetts Wealth Management's MRK Position: Q1 2026 in Review

Massachusetts Wealth Management increased its Merck (MRK) stake by 2.6% in Q1 2026, buying an estimated $69.3K and bringing the position to 23,607 shares worth $2.84M. The position accounts for 1.23% of the portfolio, ranked #27.

Massachusetts Wealth Management first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.88M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Massachusetts Wealth Management held 23,607 shares of Merck worth $2.84M as of Q1 2026.
  • Massachusetts Wealth Management bought 600 Merck shares in Q1 2026, an estimated $69.3K.
  • Merck made up 1.23% of Massachusetts Wealth Management's portfolio in Q1 2026, its #27 holding.
  • Massachusetts Wealth Management first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Massachusetts Wealth Management's Merck position peaked at $2.88M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Massachusetts Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.